Only logged in customers who have purchased this product may leave a review.

KPV + GHK – CU 60mg
- Research Grade
- 99% Purity
- Third-Party Verified
Availability: In stock
KPV + GHK – CU 60mg
R949,00
A complementary peptide blend designed to support tissue repair, skin health, and healthy inflammatory regulation. GHK-Cu is widely studied for its regenerative and collagen-supporting properties, while KPV has shown promising anti-inflammatory activity in laboratory research. Together, they offer a targeted approach to supporting recovery and cellular repair.
Availability: In stock
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About KPV + GHK – CU 60mg
GHK-Cu + KPV is a research peptide blend combining two complementary tripeptides investigated for their roles in tissue repair, extracellular matrix remodeling and inflammatory regulation. GHK-Cu is a naturally occurring copper-binding peptide studied for its effects on collagen synthesis, fibroblast activity, angiogenesis and cellular regeneration, while KPV is an α-MSH-derived tripeptide researched for anti-inflammatory activity and modulation of pathways including NF-κB. Together, the blend is investigated for its potential to support connective tissue repair, skin and epithelial integrity, cellular regeneration and balanced inflammatory signaling.
How It Works in Research
Add product-specific research mechanism content using the custom field: pl_how_it_works.
Research Applications
• Tissue regeneration • Wound healing • Collagen synthesis • Extracellular matrix remodeling • Skin regeneration • Connective tissue repair • Inflammatory regulation • Fibroblast activity • Angiogenesis • Epithelial barrier integrity
Mechanism of Action
GHK-Cu is a naturally occurring copper-binding tripeptide investigated for tissue repair, collagen synthesis, extracellular matrix remodelling, angiogenesis and cellular regeneration. Laboratory studies suggest it influences numerous genes involved in wound healing and connective tissue maintenance. KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone (α-MSH). Experimental research suggests anti-inflammatory activity through modulation of inflammatory signalling pathways including NF-κB and several pro-inflammatory cytokines while supporting epithelial barrier integrity. Together, researchers investigate whether GHK-Cu and KPV provide complementary support for tissue repair and inflammatory regulation. While encouraging laboratory findings exist, controlled human clinical studies evaluating the combination remain limited.
Potential Benefits in Research
Support collagen production and extracellular matrix remodelling.
- Promote fibroblast activity and tissue regeneration.
- Support skin quality and wound repair.
- Help regulate inflammatory signalling pathways.
- Support connective tissue recovery following injury.
- Promote healthy ageing through cellular maintenance.
- Support angiogenesis during tissue repair.
- Contribute to antioxidant defence.
Safety Profile
Mild injection-site redness, itching or tenderness may occur.
- Temporary skin discoloration may occur due to the copper component.
- Long-term human safety data for combination use remain limited.
- Most evidence comes from laboratory and animal studies.
- Use sterile preparation techniques and rotate injection sites.
REFERENCE RECONSTITUTION INFORMATION
Goal: Support connective tissue regeneration, skin quality, extracellular matrix remodelling and anti-inflammatory peptide signalling through the complementary actions of GHK-Cu and KPV. Schedule: Once-daily subcutaneous administration using a 5 days on / 2 days off protocol. Cycle Length: 8–12 weeks is commonly used in educational research frameworks. Protocols may be extended to 16 weeks where appropriate. Dose Range: • GHK-Cu: 1.5–2.5 mg daily • KPV: 0.30–0.50 mg daily Reconstitution: Add 3.0 mL bacteriostatic water to one vial containing GHK-Cu 50 mg + KPV 10 mg (20 mg/mL total concentration).
Always follow sterile preparation techniques when handling research peptides.
General Preparation
KPV + GHK - CU (10MG)- RECONSTITUTION TABLES
Reference Handling Information
Reference information for laboratory handling of KPV + GHK – CU 60mg.
- Once-daily subcutaneous administration using a 5 days on / 2 days off protocol.
Reference Parameters (Dosing Protocol)
| Week | GHK-Cu | KPV | U-100 Units | Volume |
|---|---|---|---|---|
| Weeks 1–2 | 1.5 mg | 0.30 mg | 9 units | 0.09 mL |
| Weeks 3–4 | 1.75 mg | 0.35 mg | 10.5 units | 0.105 mL |
| Weeks 5–6 | 2.0 mg | 0.40 mg | 12 units | 0.12 mL |
| Weeks 7–8 | 2.25 mg | 0.45 mg | 13.5 units | 0.135 mL |
| Weeks 9–12 | 2.5 mg | 0.50 mg | 15 units | 0.15 mL |
Experimental Study Period
View Certificate of Analysis
View Certificate of Analysis Each batch of KPV + GHK - CU is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.

Reviews
There are no reviews yet.